| |
| |
|
| Insider
Information: |
Knott David M |
| Relationship: |
10% Owner |
| City: |
Syosset |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
70,072 |
|
|
Indirect Shares
|
4,723,715 |
|
|
| Direct
Value |
$5,626,228 |
|
|
|
Indirect Value
|
$121,153,350 |
|
|
| Total
Shares |
4,793,787 |
|
|
| Total
Value |
$126,779,577 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rand Logistics Inc |
RAQCU |
10% Owner |
|
0 |
2016-04-12 |
268,135 |
Premium* |
|
|
Arrowhead Pharmaceuticals Inc |
ARWR |
10% Owner |
|
0 |
2007-03-21 |
746,900 |
Premium* |
|
|
Juniper Pharmaceuticals Inc |
JNP |
10% Owner |
2007-02-05 |
3,920 |
2007-02-05 |
140,600 |
Premium* |
|
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2015-08-17 |
66,152 |
2015-08-17 |
1,199,766 |
Premium* |
|
|
Corgi International Ltd |
CRGIY |
10% Owner |
|
0 |
2008-12-29 |
101,014 |
Premium* |
|
|
Futurefuel Corp |
FF |
10% Owner |
|
0 |
2010-01-19 |
35,800 |
Premium* |
|
|
Vaxart Inc |
VXRT |
10% Owner |
2009-01-12 |
0 |
2009-06-30 |
2,231,500 |
Premium* |
|
|
Shermen WSC Acquisition Corp |
SACQ.W |
10% Owner |
|
0 |
2013-01-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-03-03 |
4 |
B |
$11.02 |
$412,148 |
I/I |
37,400 |
20,100 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,372 |
50,705 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-10 |
4 |
B |
$10.80 |
$1,350,000 |
I/I |
125,000 |
25,700 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-11 |
4 |
B |
$11.45 |
$229,000 |
I/I |
20,000 |
347,734 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-12 |
4 |
B |
$11.99 |
$164,839 |
I/I |
13,748 |
351,182 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-15 |
4 |
B |
$11.97 |
$55,062 |
I/I |
4,600 |
352,382 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
• – – |
2011-08-17 |
4 |
B |
$12.35 |
$100,443 |
I/I |
8,133 |
354,515 |
1.99 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
• – – |
2011-08-18 |
4 |
B |
$11.91 |
$190,560 |
I/I |
16,000 |
358,615 |
1.99 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-19 |
4 |
B |
$11.96 |
$332,488 |
I/I |
27,800 |
366,015 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-22 |
4 |
B |
$12.00 |
$41,628 |
I/I |
3,469 |
367,084 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-23 |
4 |
B |
$12.18 |
$243,600 |
I/I |
20,000 |
372,484 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-24 |
4 |
B |
$12.95 |
$278,296 |
I/I |
21,490 |
28,300 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-25 |
4 |
B |
$12.57 |
$691,350 |
I/I |
55,000 |
62,783 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-26 |
4 |
B |
$12.54 |
$521,150 |
I/I |
41,559 |
397,543 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-29 |
4 |
B |
$14.21 |
$284,200 |
I/I |
20,000 |
402,843 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-30 |
4 |
B |
$14.83 |
$132,580 |
I/I |
8,940 |
404,483 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-08-31 |
4 |
B |
$14.94 |
$44,820 |
I/I |
3,000 |
405,083 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-09-01 |
4 |
B |
$15.21 |
$152,100 |
I/I |
10,000 |
407,563 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-11-10 |
4 |
B |
$11.58 |
$46,320 |
D/D |
4,000 |
54,704 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2012-01-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(28,300) |
0 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2012-05-24 |
4 |
S |
$11.62 |
$2,277,520 |
I/I |
(196,000) |
41,583 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2012-05-24 |
4 |
B |
$11.62 |
$2,277,520 |
I/I |
196,000 |
264,661 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2012-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,721 |
59,425 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2012-08-29 |
4 |
B |
$16.36 |
$44,875 |
I/I |
2,743 |
2,743 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2012-08-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(41,583) |
0 |
0 |
- |
|
176 Records found
|
|
Page 3 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
